Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies

Background: Economic evaluation of subcutaneous immunoglobulin therapy (SCIG) is important, and it has recently been used for treatment of patients with primary immunodeficiency (PID) diseases, and can improve allocation of resources in health care systems. The present research aimed at providing an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabaninejad, Hosein, Asgharzadeh, Asra, Rezapour, Aziz, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014784/
https://www.ncbi.nlm.nih.gov/pubmed/29951395
http://dx.doi.org/10.14196/mjiri.31.94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014784/
https://www.ncbi.nlm.nih.gov/pubmed/29951395
http://dx.doi.org/10.14196/mjiri.31.94

Ejemplares similares